Amgen Sees Increased Institutional Ownership Despite Assenagon's Reduced Stake

Assenagon Asset Management S.A., a global investment management firm, has reduced its stake in Amgen Inc. (NASDAQ:AMGN) by 44.5% during the second quarter, according to a recent SEC filing.

The company's holdings in Amgen were valued at $69.25 million as of the most recent filing with the SEC, which is down from the value of its previous holdings in Amgen.

Meanwhile, other institutional investors have been increasing their stakes in Amgen, including Anfield Capital Management LLC and Dogwood Wealth Management LLC, who both boosted their holdings by significant percentages during the fourth quarter.